Amphastar Pharmaceuticals, Inc.
Launch the Glucagon Injection Kit
Delivered by the deadline
AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.
- Announced
- 12 Jan 2021
- Due
- 28 Feb 2021
- Delivered
- February 2021
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“Glucagon Injection Kit launch planned February 2021”
What we found
Evidence strength A What the grades mean
Amphastar Pharmaceuticals successfully launched its glucagon for injection emergency kit in February 2021, meeting its stated commitment.
-
A Amphastar Pharmaceuticals, Inc. 10-Q filed 2021-05-07
“In December 2020, the FDA granted approval of our glucagon for injection emergency kit, 1mg, which we launched in February 2021.” ✓ confirmed on the page
Market reaction: the shares moved +6.3% against the S&P 500 over the three sessions around the disclosure (6 May 2021 to 11 May 2021). What this measures
Checked 24 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Commercial launch
- Indicative materiality
- Medium rules
- Action
- Launch
- Deliverable
- Glucagon Injection Kit
- Language
- Expected (“expects”, “plans”)
- In the company’s control
- High
- Specificity
- High
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Claude (Anthropic), re-read the evidence without being told the outcome and reached the same answer.
Confirmed. This outcome counts towards the company's Kept Score. How verification works
Are you Amphastar Pharmaceuticals, Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2021-AMPH-021935 · Corrections policy